Prevalence of metabolic syndrome in Montenegrin patients with psoriasis

Milena Ražnatović Djurović; Janko Janković; Slavenka Janković

doi:10.2298/VSP150114138R

Milena Ražnatović Djurović Clinic of Dermatology and Venereology, Clinical Center of Montenegro, Faculty of Medicine, University of Montenegro, Podgorica, Montenegro
Janko Janković Institute of Social Medicine Faculty of Medicine, University of Belgrade, Belgrade, Serbia
Slavenka Janković Institute of Epidemiology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia

DOI: https://doi.org/10.2298/VSP150114138R

Keywords: metabolic syndrome x, psoriasis, comorbidity, prevalence, risk factors, montenegro,

Abstract

Background/Aim. Increasing epidemiological studies suggest the association between psoriasis and metabolic syndrome. The aim of this study was to assess the association of metabolic syndrome and its components with psoriasis in a sample of patients from Montenegro, and to predict the factors that determine the metabolic syndrome. Methods. A case-control study was conducted at the Clinic of Dermatology and Venereology, Clinical Center of Montenegro, Podgorica, Montenegro, between January and December 2012. The study group included 101 patients with psoriasis (cases) and 126 patients with the diagnosis of dermatological disease other than psoriasis (controls) consecutively admitted to the same clinic. Results. Metabolic syndrome was more prevalent in the psoriasis patients than in the controls (48.5% vs 20.6%; OR = 2.99). In addition, the psoriasis patients were significantly more likely to be smokers (OR = 2.16) and were less physically active (OR = 0.58). Conclusion. The results of this study demonstrate a strong association between psoriasis and metabolic syndrome independent of psoriasis severity. Patients with psoriasis should be routinely screened for metabolic syndrome and its components.

References

Radtke MA, Augustin M. Economic considerations in psoriasis management. Clin Dermatol 2008; 26(5): 424−31.

Armstrong AW, Schupp C, Wu J, Bebo B. Quality of life and work productivity impairment among psoriasis patients: Findings from the National Psoriasis Foundation survey data 2003-2011. PloS One 2012; 7: e52935.

Sampogna F, Chren MM, Melchi CF, Pasquini P, Tabolli S, Abeni D. Age, gender, quality of life and psychological distress in pa-tients hospitalized with psoriasis. Br J Dermatol 2006; 154(2): 325−31.

Jankovic S, Raznatovic M, Marinkovic J, Jankovic J, Kocev N, Tomic-Spiric V, et al. Health-related quality of life in patients with psoriasis. J Cutan Med Surg 2011; 15(1): 29−36.

Sojević Timotijević Z, Janković S, Trajković G, Majcan P, Perišić S, Dostanić N, et al. Identification of psoriatic patients at risk of high quality of life impairment. Dermatol 2013; 40(10): 797−804.

Shin J, Lee J, Lim S, Ha H, Kwon H, Park Y, et al. Metabolic syndrome as a predictor of type 2 diabetes, and its clinical in-terpretations and usefulness. J Diabetes Investig 2013; 4(4): 334−43.

Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24(4): 683−9.

Klein BE, Klein R, Lee KE. Components of the metabolic syn-drome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 2002; 25(10): 1790−4.

Wilson PW. Metabolic Syndrome as a Precursor of Cardiovas-cular Disease and Type 2 Diabetes Mellitus. Circulation 2005; 112(20): 3066−72.

Langan MS, Seminara NM, Shin DB, Troxel AB, Kimmel SE, Meh-ta NN, et al. Prevalence of metabolic syndrome in patients with psoriasis: A population-based study in the United King-dom. J Invest Dermatol 2012; 132(2): 556−62.

Miller IM, Ellervik C, Zarchi K, Ibler KS, Vinding GR, Knudsen KM, et al. The association of metabolic syndrome and psoriasis: A population- and hospital-based cross-sectional study. J Eur Acad Dermatol Venereol 2015; 29(3): 490−7.

Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006; 55(5): 829−35.

Mallbris L, Ritchlin CT, Ståhle M. Metabolic disorders in patients with psoriasis and psoriatic arthritis. Curr Rheumatol Rep 2006; 8(5): 355−63.

Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A, et al. Prevalence of metabolic syndrome in patients with psoria-sis: A hospital based case-control study. Br J Dermatol 2007; 157(1): 68−73.

Ryan C, Kirby B. Psoriasis is a systematic disease with multiple cardiovascular and metabolic comorbidities. Dermatol Clin 2015; 33(1): 41−55.

Menter MA, Griffiths CE. Psoriasis: the future. Dermatol Clin 2015; 33(1): 161−6.

Fredriksson T, Pettersson U. Severe psoriasis: Oral therapy with a new retinoid. Dermatologica 1978; 157(4): 238−44.

World Health Organization. Body mass index. Available from: http://www.euro.who.int/en/health-topics/disease-prevention/nutrition/a-healthy-lifestyle/body-mass-index-bmi

Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112(17): 2735−52.

Love TJ, Qureshi AA, Karlson EW, Gelfand JM, Choi HK. Preva-lence of the metabolic syndrome in psoriasis: Results from the National Health and Nutrition Examination Survey, 2003-2006. Arch Dermatol 2011; 147(4): 419−24.

Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006; 298(7): 321−8.

Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and me-tabolic syndrome: A systematic review and meta-analysis of observational studies. J Am Acad Dermatol 2013; 68(4): 654−62.

Albareda M, Ravella A, Castelló M, Saborit S, Peramiquel L, Vila L. Metabolic syndrome and its components in patients with psoriasis. Springerplus 2014; 3: 612.

Danielsen K, Wilsgaard T, Olsen AO, Eggen AE, Olsen K, Cassano PA, et al. Elevated odds of metabolic syndrome in psoriasis: A population-based study of age and sex differences. Br J Dermatol 2015; 172(2): 419−27.

Lakshmi S, Nath AK, Udayashankar C. Metabolic syndrome in patients with psoriasis: A comparative study. Indian Dermatol Online J 2014; 5(2): 132−7.

Kim G, Park H, Kim H, Kim S, Ko H, Kim B, et al. Analysis of cardiovascular risk factors and metabolic syndrome in Korean patients with psoriasis. Ann Dermatol 2012; 24(1): 11−5.

Mebazaa A, El AM, Zidi W, Zayani Y, Cheikh RR, El OS, et al. Metabolic syndrome in Tunisian psoriatic patients: Prevalence and determinants. J Eur Acad Dermatol Venereol 2011; 25(6): 705−9.

Cohen AD, Gilutz H, Henkin Y, Zahger D, Shapiro J, Bonneh DY, et al. Psoriasis and the Metabolic Syndrome. Acta Derm Ve-nereol 2007; 87(6): 506−9.

Nisa N, Qazi MA. Prevalence of metabolic syndrome in pa-tients with psoriasis. Indian J Dermatol Venereol Leprol 2010; 76(6): 662−5.

Zindanci I, Albayrak O, Kavala M, Kocaturk E, Can B, Sudogan S, et al. Prevalence of Metabolic Syndrome in Patients with Pso-riasis. Sci World J 2012; 2012: 312463.

Herron MD, Hinckley M, Hoffman MS, Papenfuss J, Hansen CB, Callis KP, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005; 141(12): 1527−34.

Wolk K, Mallbris L, Larsson P, Rosenblad A, Vingård E, Ståhle M. Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis. Acta Derm Venereol 2009; 89(5): 492−7.

Armstrong AW, Harskamp CT, Dhillon JS, Armstrong EJ. Psoriasis and smoking: A systematic review and meta-analysis. Br J Dermatol 2014; 170(2): 304−14.

Naldi L, Chatenoud L, Linder D, Belloni FA, Peserico A, Virgili AR, et al. Cigarette Smoking, Body Mass Index, and Stressful Life Events as Risk Factors for Psoriasis: Results from an Italian Case-Control Study. J Invest Dermatol 2005; 125(1): 61−7.

Naldi L, Peli L, Parazzini F, Carrel CF. Family history of psoria-sis, stressful life events, and recent infectious disease are risk factors for a first episode of acute guttate psoriasis: Results of a case-control study. J Am Acad Dermatol 2001; 44(3): 433−8.

Jankovic S, Raznatovic M, Marinkovic J, Jankovic J, Maksimovic N. Risk factors for psoriasis: A case-control study. J Dermatol 2009; 36(6): 328−34.

Gisondi P, Ferrazzi A, Girolomoni G. Metabolic Comorbidities and Psoriasis. Acta Dermatovenerol Croat 2010; 18(4): 297−304.

Takahashi H, Iizuka H. Psoriasis and metabolic syndrome. J Dermatol 2012; 39(3): 212−8.

Baeta IG, Bittencourt FV, Gontijo B, Goulart EM. Comorbidities and cardiovascular risk factors in patients with psoriasis. An Bras Dermatol 2014; 89(5): 735−44.

Naldi L, Addis A, Chimenti S, Giannetti A, Picardo M, Tomino C, et al. Impact of body mass index and obesity on clinical re-sponse to systemic treatment for psoriasis. Evidence from the Psocare project. Dermatology (Basel) 2008; 217(4): 365−73.

Prizment AE, Alonso A, Folsom AR, Ahmed RL, Virnig BA, War-shaw EM, et al. Association between psoriasis and incident cancer: the Iowa's Women's Health Study. Cancer Causes Control 2011; 22(7): 1003−10.

Raychaudhuri SP, Gross J. Psoriasis risk factors: Role of lifestyle practices. Cutis 2000; 66(5): 348−52.

Balato N, Megna M, Palmisano F, Patruno C, Napolitano M, Scalvenzi M, et al. Psoriasis and sport: A new ally. J Eur Acad Dermatol Venereol 2015; 29(3): 515−20.

Frankel HC, Han J, Li T, Qureshi AA. The Association Between Physical Activity and the Risk of Incident Psoriasis. Arch Dermatol 2012; 148(8): 918−24.

Qureshi AA, Choi HK, Setty AR, Curhan GC. Psoriasis and the risk of diabetes and hypertension: A prospective study of US female nurses. Arch Dermatol 2009; 145(4): 379−82.

Wilson PB, Bohjanen KA, Ingraham SJ, Leon AS. Psoriasis and physical activity: A review. J Eur Acad Dermatol Venereol 2012; 26(11): 1345−53.

Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and hypertension: A systematic review and meta-analysis of observational studies. J Hypertens 2013; 31(3): 433−42.

Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and the risk of diabetes mellitus: A systematic review and meta-analysis. JAMA Dermatol 2013; 149(1): 84−91.